Drug Licensing Activity Report Q1 2010
By
After a stellar rise in Q4 2009, the total value of drug licensing agreements has taken a nosedive in
Q1 2010. The quarter has seen 133 agreements valued at USD 8.4bn, a staggering decrease of 52% by value from Q4 2009, in which 146 agreements with a total value of USD 17.4bn were announced.